Zymeworks appoints Dr. Cesano to board; Dr. Hillan resigns after 7 years

Zymeworks Inc.

Dr. Alessandra Cesano appointed to board effective Feb 8, 2024, as Class I director with term expiring at 2025 AGM.
Dr. Kenneth Hillan resigned Feb 6, effective Feb 8, not due to disagreement; he served 7 years on the board.
Cesano receives initial option to purchase 74,000 shares per standard non-employee director compensation plan.
Cesano appointed to nominating & governance and R&D committees; Derek Miller becomes chair of nominating committee.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alessandra Cesano

Director

ZYME · Zymeworks Inc.

Effective: 2024-02-08
Filed: February 8, 2024, 6:59 PM ET

appointed Dr. Alessandra Cesano as a director of the Company, effective as of February 8, 2024.

Departed

Kenneth Hillan

Director

ZYME · Zymeworks Inc.

Effective: 2024-02-08
Filed: February 8, 2024, 6:59 PM ET

Dr. Kenneth Hillan submitted his resignation from the Board, including as chair and member of the nominating and corporate governance committee and as member of the research and development committee of the Board, effective February 8, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alessandra Cesano was appointed as Director at Zymeworks Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Dr. Alessandra Cesano as a director of the Company, effective as of February 8, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kenneth Hillan resigned as Director at Zymeworks Inc..

Action: resigned
Role: Director

Exact text from the filing

Dr. Kenneth Hillan submitted his resignation from the Board, including as chair and member of the nominating and corporate governance committee and as member of the research and development committee of the Board, effective February 8, 2024.

View on SEC.gov

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-028369

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.